Balarí, A. S., Khan, A., Oriol, A., Mesa, M. G., Anwer, F., Encinas, C., Lipe, B., Rodriguez-Otero, P., Chen, P., Lin, H., Jin, K., Solomon, T., Taningco, L., Aina, O., Maciag, P., Lonial, S. (2025). Iberdomide plus daratumumab and dexamethasone (IberDd) in patients with newly diagnosed multiple myeloma by renal function: A subgroup analysis of the CC-220-MM-001 trial. Blood. https://doi.org/10.1182/blood-2025-5810